Mesenchymal Stem Cell Therapy For COVID-19; Is A New Challenge Review

Maged Naser, Mohamed MN, Lamia H. Shehata

Abstract


"Coronavirus" is the word that absolutely isn't forgotten by everybody who lives in the first half of the twenty-first century. COVID19, as a pandemic, has driven numerous researchers from various biomedical fields to discover arrangements or therapies to deal with the pandemic. Nonetheless, no standard treatment for this infection has been found to date. Presumably, preventing the acute severe respiratory   infection type of COVID-19 as the most risky period of this disease can be useful for the therapy and decrease of the death rate.

 In such manner, mesenchymal stem cells (MSCs)-based immunomodulation treatment has been proposed as a reasonable restorative methodology and a several clinical studies have started. Recently, MSCs as indicated by their immunomodulatory and regenerative properties stand out in clinical trials. After the intravenous transplantation of MSCs, a large population of cells gathers in the lung, which they close by immunomodulatory impact could protect alveolar epithelial cells, recover the respiratory microenvironment, prevent pneumonic fibrosis, and cure lung dysfunction. Given the vulnerabilities here, we checked on detailed clinical preliminaries and theories to give helpful data to scientists and those keen on stem cell therapy.

In this study, we considered this new way to deal with improve patient's immunological reactions to COVID-19 utilizing MSCs and talked about the parts of this proposed treatment. Nonetheless, right now, there are no affirmed MSC-based methodologies for the anticipation or potentially treatment of COVID-19 patients however clinical preliminaries progressing.  


Keywords


(COVID-19, Mesenchymal stem cells, stem cell treatment, Immunomodulatory, Clinical trials).

Full Text:

PDF

References


- Wu, Fan, et al. "A new coronavirus associated with human respiratory disease in China." Nature 579.7798 (2020): 265-269.‏

- Metcalfe, Su M. "Mesenchymal stem cells and management of COVID-19 pneumonia." Medicine in drug discovery 5 (2020): 100019.‏

- Golchin, Ali, Ehsan Seyedjafari, and Abdolreza Ardeshirylajimi. "Mesenchymal stem cell therapy for COVID-19: present or future." Stem cell reviews and reports 16.3 (2020): 427-433.‏

- Wong, Antonio CP, et al. "Global epidemiology of bat coronaviruses." Viruses 11.2 (2019): 174.‏

- Woo, Patrick CY, et al. "Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features." Journal of virology 81.4 (2007): 1574-1585.‏

- Zhou, Peng, et al. "A pneumonia outbreak associated with a new coronavirus of probable bat origin." nature 579.7798 (2020): 270-273.‏

- Zhu, Na, et al. "China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019." N Engl J Med 382.8 (2020): 727-733.‏

- Park, Wan Beom, et al. "Virus isolation from the first patient with SARS-CoV-2 in Korea." Journal of Korean medical science 35.7 (2020).‏

- Govorkova, E. A., et al. "African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses." Journal of virology 70.8 (1996): 5519-5524.‏

- Hoffmann, Markus, et al. "The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells." BioRxiv (2020).‏

- Li, Fang, et al. "Structure of SARS coronavirus spike receptor-binding domain complexed with receptor." Science 309.5742 (2005): 1864-1868.‏

- Shankar, Abhishek, et al. "Cancer care delivery challenges amidst coronavirus disease–19 (COVID-19) outbreak: specific precautions for cancer patients and cancer care providers to prevent spread." Asian Pacific journal of cancer prevention: APJCP 21.3 (2020): 569.‏

- Ji, Yunpeng, et al. "Potential association between COVID-19 mortality and health-care resource availability." The Lancet Global Health 8.4 (2020): e480.‏

- Spychalski, Piotr, Agata Błażyńska-Spychalska, and Jarek Kobiela. "Estimating case fatality rates of COVID-19." The Lancet. Infectious Diseases (2020).‏

- Backer, Jantien A., Don Klinkenberg, and Jacco Wallinga. "Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020." Eurosurveillance 25.5 (2020): 2000062.‏

- AL, BİLGİ. "Kök Hücreyle Covid 19 Tedavisi Mümkün."‏

- Russell, Clark D., Jonathan E. Millar, and J. Kenneth Baillie. "Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury." The Lancet 395.10223 (2020): 473-475.‏

- Vickers, Neil J. "Animal communication: when i’m calling you, will you answer too?" Current biology 27.14 (2017): R713-R715.‏

- Hamming, Inge, et al. "Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis." The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland 203.2 (2004): 631-637.‏

- Baruah, Vargab, and Sujoy Bose. "Immunoinformatics‐aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019‐nCoV." Journal of medical virology 92.5 (2020): 495-500.‏

- Bhattacharya, Manojit, et al. "Development of epitope‐based peptide vaccine against novel coronavirus 2019 (SARS‐COV‐2): Immunoinformatics approach." Journal of medical virology 92.6 (2020): 618-631.‏

- Golchin, Ali, and Tahereh Zarnoosheh Farahany. "Biological products: cellular therapy and FDA approved products." Stem cell reviews and reports 15.2 (2019): 166-175.‏

- Golchin, Ali, et al. "The clinical trials of mesenchymal stem cell therapy in skin diseases: an update and concise review." Current stem cell research & therapy 14.1 (2019): 22-33.‏

- Mehta, P., et al. "Across Speciality (2020)." COVID‐19: Consider cytokine storm syndromes and immunosuppression. The Lancet (London, England) 395.10229: 1033.‏

- Leng, Zikuan, et al. "Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia." Aging and disease 11.2 (2020): 216.‏

- Golchin, Ali, Forough Shams, and Farshid Karami. "Advancing Mesenchymal stem cell therapy with CRISPR/Cas9 for clinical trial studies." Cell Biology and Translational Medicine, Volume 8: Stem Cells in Regenerative Medicine (2020): 89-100.‏

- Novello, Solen, et al. "Clinical application of mesenchymal stem cells in periodontal regeneration: A systematic review and meta‐analysis." Journal of periodontal research 55.1 (2020): 1-12.‏

- Zhao, Ke, and Qifa Liu. "The clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantation." Journal of hematology & oncology 9.1 (2016): 1-9.‏

- Chen, Jiajia, et al. "Clinical study of mesenchymal stem cell treatment for acute respiratory distress syndrome induced by epidemic influenza A (H7N9) infection: a hint for COVID-19 treatment." Engineering 6.10 (2020): 1153-1161.‏

- Liang, Bing, et al. "Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells: A case report." Medicine 99.31 (2020).‏




DOI: http://dx.doi.org/10.52155/ijpsat.v25.1.2795

Refbacks

  • There are currently no refbacks.


Copyright (c) 2021 Maged Naser, Mohamed MN, Lamia H. Shehata

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.